vs

Side-by-side financial comparison of CLEAN HARBORS INC (CLH) and Zoetis (ZTS). Click either name above to swap in a different company.

Zoetis is the larger business by last-quarter revenue ($2.4B vs $1.5B, roughly 1.6× CLEAN HARBORS INC). Zoetis runs the higher net margin — 25.3% vs 5.8%, a 19.5% gap on every dollar of revenue. On growth, CLEAN HARBORS INC posted the faster year-over-year revenue change (4.8% vs 3.0%). Zoetis produced more free cash flow last quarter ($732.0M vs $233.3M). Over the past eight quarters, Zoetis's revenue compounded faster (4.4% CAGR vs 4.4%).

Clean Harbors, Inc., headquartered in Norwell, Massachusetts, is a provider of waste management and industrial services for commercial customers, specializing in the collection, transportation, treatment and disposal of hazardous waste, but also offering services for non-hazardous waste. The company has 870 operating locations in 630 properties in the U.S. and Canada including a network of over 100 waste disposal facilities such as incinerators, landfills, treatment, storage and disposal faci...

Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...

CLH vs ZTS — Head-to-Head

Bigger by revenue
ZTS
ZTS
1.6× larger
ZTS
$2.4B
$1.5B
CLH
Growing faster (revenue YoY)
CLH
CLH
+1.8% gap
CLH
4.8%
3.0%
ZTS
Higher net margin
ZTS
ZTS
19.5% more per $
ZTS
25.3%
5.8%
CLH
More free cash flow
ZTS
ZTS
$498.7M more FCF
ZTS
$732.0M
$233.3M
CLH
Faster 2-yr revenue CAGR
ZTS
ZTS
Annualised
ZTS
4.4%
4.4%
CLH

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLH
CLH
ZTS
ZTS
Revenue
$1.5B
$2.4B
Net Profit
$86.6M
$603.0M
Gross Margin
30.6%
70.2%
Operating Margin
10.6%
31.9%
Net Margin
5.8%
25.3%
Revenue YoY
4.8%
3.0%
Net Profit YoY
3.1%
3.8%
EPS (diluted)
$1.62
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLH
CLH
ZTS
ZTS
Q4 25
$1.5B
$2.4B
Q3 25
$1.5B
$2.4B
Q2 25
$1.5B
$2.5B
Q1 25
$1.4B
$2.2B
Q4 24
$1.4B
$2.3B
Q3 24
$1.5B
$2.4B
Q2 24
$1.6B
$2.4B
Q1 24
$1.4B
$2.2B
Net Profit
CLH
CLH
ZTS
ZTS
Q4 25
$86.6M
$603.0M
Q3 25
$118.8M
$721.0M
Q2 25
$126.9M
$718.0M
Q1 25
$58.7M
$631.0M
Q4 24
$84.0M
$581.0M
Q3 24
$115.2M
$682.0M
Q2 24
$133.3M
$624.0M
Q1 24
$69.8M
$599.0M
Gross Margin
CLH
CLH
ZTS
ZTS
Q4 25
30.6%
70.2%
Q3 25
32.3%
71.5%
Q2 25
33.3%
73.6%
Q1 25
28.6%
72.0%
Q4 24
29.9%
69.5%
Q3 24
31.0%
70.6%
Q2 24
33.3%
71.7%
Q1 24
29.5%
70.6%
Operating Margin
CLH
CLH
ZTS
ZTS
Q4 25
10.6%
31.9%
Q3 25
12.5%
37.0%
Q2 25
13.6%
36.7%
Q1 25
7.8%
36.5%
Q4 24
9.6%
31.6%
Q3 24
12.6%
36.6%
Q2 24
13.9%
33.0%
Q1 24
9.1%
34.1%
Net Margin
CLH
CLH
ZTS
ZTS
Q4 25
5.8%
25.3%
Q3 25
7.7%
30.0%
Q2 25
8.2%
29.2%
Q1 25
4.1%
28.4%
Q4 24
5.9%
25.1%
Q3 24
7.5%
28.6%
Q2 24
8.6%
26.4%
Q1 24
5.1%
27.4%
EPS (diluted)
CLH
CLH
ZTS
ZTS
Q4 25
$1.62
$1.37
Q3 25
$2.21
$1.63
Q2 25
$2.36
$1.61
Q1 25
$1.09
$1.41
Q4 24
$1.55
$1.29
Q3 24
$2.12
$1.50
Q2 24
$2.46
$1.37
Q1 24
$1.29
$1.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLH
CLH
ZTS
ZTS
Cash + ST InvestmentsLiquidity on hand
$127.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.7B
$3.3B
Total Assets
$7.6B
$15.5B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLH
CLH
ZTS
ZTS
Q4 25
$127.4M
Q3 25
$91.2M
$2.1B
Q2 25
$98.9M
$1.4B
Q1 25
$105.9M
$1.7B
Q4 24
$102.6M
$2.0B
Q3 24
$82.4M
$1.7B
Q2 24
$91.3M
$1.6B
Q1 24
$104.8M
$2.0B
Stockholders' Equity
CLH
CLH
ZTS
ZTS
Q4 25
$2.7B
$3.3B
Q3 25
$2.8B
$5.4B
Q2 25
$2.7B
$5.0B
Q1 25
$2.6B
$4.7B
Q4 24
$2.6B
$4.8B
Q3 24
$2.5B
$5.2B
Q2 24
$2.4B
$5.0B
Q1 24
$2.3B
$5.1B
Total Assets
CLH
CLH
ZTS
ZTS
Q4 25
$7.6B
$15.5B
Q3 25
$7.5B
$15.2B
Q2 25
$7.4B
$14.5B
Q1 25
$7.2B
$14.1B
Q4 24
$7.4B
$14.2B
Q3 24
$7.3B
$14.4B
Q2 24
$7.1B
$14.2B
Q1 24
$6.9B
$14.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLH
CLH
ZTS
ZTS
Operating Cash FlowLast quarter
$355.1M
$893.0M
Free Cash FlowOCF − Capex
$233.3M
$732.0M
FCF MarginFCF / Revenue
15.6%
30.7%
Capex IntensityCapex / Revenue
8.1%
6.7%
Cash ConversionOCF / Net Profit
4.10×
1.48×
TTM Free Cash FlowTrailing 4 quarters
$441.8M
$2.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLH
CLH
ZTS
ZTS
Q4 25
$355.1M
$893.0M
Q3 25
$302.0M
$938.0M
Q2 25
$208.0M
$486.0M
Q1 25
$1.6M
$587.0M
Q4 24
$303.9M
$905.0M
Q3 24
$239.2M
$951.0M
Q2 24
$216.0M
$502.0M
Q1 24
$18.5M
$595.0M
Free Cash Flow
CLH
CLH
ZTS
ZTS
Q4 25
$233.3M
$732.0M
Q3 25
$207.5M
$805.0M
Q2 25
$118.0M
$308.0M
Q1 25
$-117.1M
$438.0M
Q4 24
$241.5M
$689.0M
Q3 24
$142.4M
$784.0M
Q2 24
$80.9M
$370.0M
Q1 24
$-119.4M
$455.0M
FCF Margin
CLH
CLH
ZTS
ZTS
Q4 25
15.6%
30.7%
Q3 25
13.4%
33.5%
Q2 25
7.6%
12.5%
Q1 25
-8.2%
19.7%
Q4 24
16.9%
29.7%
Q3 24
9.3%
32.8%
Q2 24
5.2%
15.7%
Q1 24
-8.7%
20.8%
Capex Intensity
CLH
CLH
ZTS
ZTS
Q4 25
8.1%
6.7%
Q3 25
6.1%
5.5%
Q2 25
5.8%
7.2%
Q1 25
8.3%
6.7%
Q4 24
4.4%
9.3%
Q3 24
6.3%
7.0%
Q2 24
8.7%
5.6%
Q1 24
10.0%
6.4%
Cash Conversion
CLH
CLH
ZTS
ZTS
Q4 25
4.10×
1.48×
Q3 25
2.54×
1.30×
Q2 25
1.64×
0.68×
Q1 25
0.03×
0.93×
Q4 24
3.62×
1.56×
Q3 24
2.08×
1.39×
Q2 24
1.62×
0.80×
Q1 24
0.27×
0.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLH
CLH

Technical Services$479.3M32%
Safetly Kleen Environmental Services$252.9M17%
Fieldand Emergency Response$246.6M16%
Products$205.3M14%
Safety Kleen Sustainability Solutions Segment$188.4M13%
Safety Kleen Oil$132.6M9%

ZTS
ZTS

Other$1.3B56%
Livestock$234.0M10%
Pain Sedation$209.0M9%
Other Pharmaceuticals$188.0M8%
Swine$125.0M5%
Poultry$117.0M5%
Fish$81.0M3%
Other Non Pharmaceuticals$70.0M3%
Manufactured Product Other$18.0M1%
Medicated Feed Additives$12.0M1%

Related Comparisons